Egis Pharmaceuticals plc owns invention patent No. 200980138060.7 (the Subject Patent), which relates to a pharmaceutical composition containing amlodipine besylate and bisoprolol fumarate. On March ...

Patients were randomised to receive nebivolol (5mg orally daily) or bisoprolol (10mg orally daily) for 2 weeks, followed by a 2-week washout and 2 weeks of the other treatment. Measurements (by ...

The study was a double-blind, randomised, crossover, single-centre investigation comparing nebivolol with bisoprolol in 15 patients with essential hypertension. Study participants were screened ...

What is Tecfidera for MS? Tecfidera (dimethyl fumarate) is an approved oral therapy indicated for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome ...

An Indian expert panel has issued a consensus statement highlighting the role of bisoprolol across the cardiovascular care continuum, with a special focus on women. Published in the latest issue of ...

What is Bafiertam for MS? Bafiertam (monomethyl fumarate) is an oral therapy that’s approved in the U.S. for adults with relapsing forms of multiple sclerosis, such as clinically isolated ...

A novel treatment for hard-to-control high blood pressure has shown strong results in a major global clinical trial. The Phase 3 Launch-HTN study found that lorundrostat, an aldosterone synthase ...